Skip to main content
SpringerLink
Log in

HIV in der Schwangerschaft: Gefahr gebannt?

HIV during pregnancy: no longer a risk?

  • Gynäkologie aktuell
  • Published:
Der Gynäkologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Literatur

  1. Robert Koch-Institut (2016) Ratgeber für Ärzte: HIV/AIDS. http://www.rki.de/DE/Content/Infekt/EpidBull/Merkblaetter/Ratgeber_HIV_AIDS.html?nn=2374210. Zugegriffen: 24. Aug. 2017

    Google Scholar 

  2. Barré-Sinoussi F, Chermann JC, Rey F et al (1983) Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220(4599):868–887

    Article  PubMed  Google Scholar 

  3. Patel P, Borkowf CB, Brooks JT et al (2014) Estimating per-act HIV transmission risk: a systematic review. AIDS 28(10):1509–1519

    Article  PubMed  Google Scholar 

  4. Center for Disease Control and Prevention (1993) Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. JAMA 269(6):729–730

    Article  Google Scholar 

  5. UNAIDS (2017) Global HIV statistics. Fact sheet (2017). http://www.unaids.org/en/resources/fact-sheet. Zugegriffen: 24. Aug. 2017

    Google Scholar 

  6. Robert Koch-Institut (2016) Schätzung der Zahl der HIV-Neuinfektionen und der Gesamtzahl von Menschen mit HIV in Deutschland. Epidemiol Bull 45:497–509

    Google Scholar 

  7. European Group CS (1991) Children born to women with HIV-1 infection: natural history and risk of vertical transmission. Lancet 337:253–260

    Article  Google Scholar 

  8. AWMF (2017) Deutsch-österreichische Leitlinie zur HIV-Therapie in der Schwangerschaft und bei HIV-exponierten Neugeborenen. AWMF Leitlinie Registernr. 055-002. http://www.awmf.org/leitlinien/detail/ll/055-002.html. Zugegriffen: 24. Aug. 2017

    Google Scholar 

  9. Abrams EJ (2010) Paper 22. 17th CROI Plenary, 17.2.2010

    Google Scholar 

  10. Garcia PM, Kalish LA, Pitt J et al (1999) Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and infants transmission study group. N Engl J Med 341(6):394–402

    Article  CAS  PubMed  Google Scholar 

  11. Ioannidis JPA, Abrams EJ, Ammann A et al (2001) Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads < 1000 copies/mL. J Infect Dis 183(4):539–545

    Article  CAS  PubMed  Google Scholar 

  12. Gemeinsamer Bundesausschuss (2016) Richtlinien über die ärztliche Betreuung während der Schwangerschaft und nach der Entbindung. https://www.g-ba.de/informationen/richtlinien/19/. Zugegriffen: 24. Aug. 2017

    Google Scholar 

  13. Arab K, Spence AR, Czuzoj-Shulman N et al (2017) Pregnancy outcomes in HIV-positive women: a retrospective cohort study. Arch Gynecol Obstet 295(3):599–606

    Article  PubMed  Google Scholar 

  14. Tai JH, Udoji MA, Barkanic G et al (2007) Pregnancy and HIV disease progression during the era of highly active antiretroviral therapy. J Infect Dis 196(7):1044–1052

    Article  PubMed  Google Scholar 

  15. Wright TC Jr, Subbarao S, Ellerbrock TV et al (2001) Human immunodeficiency virus 1 expression in the female genital tract in association with cervical inflammation and ulceration. Am J Obstet Gynecol 184(3):279–285

    Article  PubMed  Google Scholar 

  16. Conley LJ, Ellerbrock TV, Bush TJ et al (2002) HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia: a prospective cohort study. Lancet 359(9301):108–113

    Article  PubMed  Google Scholar 

  17. Saif MW, Bona R, Greenberg B (2001) AIDS and thrombosis: retrospective study of 131 HIV-infected patients. AIDS Patient Care STDS 15(6):311–320

    Article  CAS  PubMed  Google Scholar 

  18. Jansen JM, Lijfering WM, Sprenger HG et al (2008) Venous thromboembolism in HIV-positive women during puerperium: a case series. Blood Coagul Fibrinolysis 19(1):95–97

    Article  PubMed  Google Scholar 

  19. Thorne C et al (2000) Combination antiretroviral therapy and duration of pregnancy. 14. European collaborative study and the Swiss mother and child HIV cohort study. AIDS 14:2913–2920

    Article  Google Scholar 

  20. Tuomala RE, Shapiro DE, Mofenson LM et al (2002) Antiretroviral therapy during pregnancy and the risk of an adverse outcome. N Engl J Med 346(24):1863–1870

    Article  PubMed  Google Scholar 

  21. González-Tomé MI, Ramos Amador JT, Guillen S (2008) Gestational diabetes mellitus in a cohort of HIV-1 infected women. HIV Med 9(10):868–874

    Article  PubMed  Google Scholar 

  22. Little SJ, Holte S, Routy JP et al (2002) Antiretroviral-drug resistance among patients recently infected with HIV. N Engl J Med 347(6):385–394

    Article  CAS  PubMed  Google Scholar 

  23. Warszawski J, Tubiana R, Le Chenadec J et al (2008) Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French perinatal cohort. AIDS 22(2):289–299

    Article  PubMed  Google Scholar 

  24. CDC (1994) Recomendations of the U‑S. Public health service task force on the use of Zidovudine to reduce perinatal transmission of human immunodeficiency virus. MMWR Morb Mortal Wkly Rep 43(RR11):1–20

    Google Scholar 

  25. Nielsen-Saines K, Watts DH, Veloso VG et al (2012) Three postpartum antiretroviral regimens to prevent intrapartum HIV infection. N Engl J Med 366(25):2368–2379

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Nduati R, John G, Mbori-Ngacha D et al (2000) Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA 283(9):1167–1174

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Gynäkologie und Geburtshilfe, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Arnold-Heller-Straße 3, 24105, Kiel, Deutschland

    Kerstin Eckhoff, André Farrokh & Nicolai Maass

  2. Klinik für Innere Medizin II, Infektiologie, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Arnold-Heller-Straße 3, 24105, Kiel, Deutschland

    Tom Vieler

Authors
  1. Kerstin Eckhoff
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. André Farrokh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tom Vieler
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nicolai Maass
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kerstin Eckhoff.

Ethics declarations

Interessenkonflikt

K. Eckhoff, A. Farrokh, T. Vieler und N. Maass geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.

Additional information

Redaktion

T. Fehm, Düsseldorf

R. Kimmig, Essen

N. Maass, Kiel

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Eckhoff, K., Farrokh, A., Vieler, T. et al. HIV in der Schwangerschaft: Gefahr gebannt?. Gynäkologe 51, 238–242 (2018). https://doi.org/10.1007/s00129-018-4208-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00129-018-4208-6

Search

Navigation